Related Experiment Video
Updated: Apr 9, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
[Thrombogenesis and its treatment in portal system after devascularization]
Objective:
To discuss the occurrence of thrombosis in portal system of patients with cirrhotic portal hypertension after devascularization and the methods for treatment and prevention.
Methods:
The clinical data of 113 patients with cirrhotic portal hypertension after the devascularization were collected and analyzed retrospectively, and the occurrence time, parts as well as the treatment and prevention methods were discussed.
Results:
Among the 113 patients, 33 of them were found with thrombosis in their portal system, and the occurrence rate was 29.2%. The occurrence time of thrombosis was 2-15 days post-devascularization, and the median time was 6 days post-operation. Among the 33 cases with thrombosis, there were 19 cases of splenic vein thrombosis, 10 cases of portal thrombosis, and 4 cases of both of them. After the thrombolytic therapy, the thrombosises in 30 cases disappeared.
Conclusions:
Most of the thrombosises in portal system happen in splenic vein post-devascularization. Avoiding clamping the trunk of splenic vein in the operation and taking thrombolytic therapy at the early stage after the operation can effectively prevent the occurrence of thrombosis.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...

